{"version":"1.0","type":"link","title":"Phase 2 feasibility study of adjuvant chemotherapy with cisplatin (CDDP) and TS-1, followed by alternate-day TS-1 maintenance therapy, in patients with completely resected pathological stage II-IIIA non-small cell lung cancer.","author_name":"Fujino K 외","author_url":"https://prs-insight.online/author/Fujino%20K","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/101592","thumbnail_width":1200,"thumbnail_height":630}